WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

BridgeBio adds $1B as it prepares three more drug launches

BridgeBio raises $1B via preferred equity from Sixth Street and KKR's HealthCare Royalty, stockpiling cash ahead of three drug launches within 18 months.

Raccontata daendpoints.newsfiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo12 h fa

BridgeBio adds $1B as it prepares three more drug launches

BridgeBio raises $1B via preferred equity from Sixth Street and KKR's HealthCare Royalty, stockpiling cash ahead of three drug launches within 18 months.

originale
fiercepharma.com11 h fa

BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’

Things are happening fast at BridgeBio as it plugs away at the launch of blockbuster-in-waiting Attruby and prepares to potentially introduce three new drugs to the market within the next 12 months | As BridgeBio ramps…

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 1 luglio 2026·endpoints.news

    BridgeBio adds $1B as it prepares three more drug launches

    BridgeBio raises $1B via preferred equity from Sixth Street and KKR's HealthCare Royalty, stockpiling cash ahead of three drug launches within 18 months.

  2. mercoledì 1 luglio 2026·fiercepharma.com

    BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’

    Things are happening fast at BridgeBio as it plugs away at the launch of blockbuster-in-waiting Attruby and prepares to potentially introduce three new drugs to the market within…